Summary
Cetiedil, a new vasodilating drug with anticholinergic properties, was shown to be metabolised very rapidly in man after intravenous and oral administration of the14C-compound. Higher concentrations of labelled compound after oral than after intravenous administration at the same sampling time, and proportional differences in urinary excretion, suggest that metabolic handling of the drug differs depending on the route of administration. Experiments in which inhibition of saliva secretion was measured indicated that (an) active metabolite(s) probably was (were) responsible for the action of the drug. As an anticholinergic drug, cetiedil is at least 400 times weaker than atropine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boissier, J.R., Aurousseau, M., Giudicelli, J.F., Duval, D.: Communication présentée à la séance de la Société Française de Thérapeutique et de Pharmacodynamie, 16 Janvier 1974
Boissier, J.R., Tillement, J.P., Singlas, E., Thebault, J.: Distribution et élimination de cétiedil-14C après injection intraveineuse chez le rat. Europ. J. med. Chem.9, 534–538 (1974)
Gray, W., Riseman, J.E.F., Stearns, S.: Papaverine in the treatment of coronary-artery disease. New Engl. J. Med.232, 389–394 (1945)
Herxheimer, A., Haefeli, L.: Human pharmacology of hyoscine butylbromide. Lancet1966 II, 418–421
Linquette, M.: Communication on clinical evaluation of Cetiedil (Innothéra). Lille Mixed Medicine and Pharmacy Faculty, France (1971)
Linquette, M., Fossati, P., Luez, G.: Intérêt thérapeutique d'une nouvelle médication anti-ischémique et vaso-régulatrice: Le cétiedil. Lille Méd. Actual.18, 1303–1312 (1973)
McHenry, L. C., Jaffe, M. E., Kawamura, J., Goldberg, H. I.: Effect of papaverine on regional blood flow in focal vascular disease of the brain. New Engl. J. Med.282, 1167–1170 (1970)
Robba, M., Le Guen, Y.: Dérivés thiophéniques β-substitués. III-Esters aminés des acides α-phényl, α-cyclopentyl et α-cyclohexyl — α(thienyl-3) acétiques. Chim. Thér.2, 120–124 (1967)
Simaan, J.A., Aviado, D.M.: A comparative study between the cardiovascular effects of cetiedil, a new vasodilator, and papaverine and aminophylline. J. Pharmacol. Exp. Ther.198, 176–186 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Soeterboek, A.M., Scaf, A.H.J., Lammers, W. et al. Human experience of cetiedil, a new vasodilator with anticholinergic properties. Eur J Clin Pharmacol 12, 205–208 (1977). https://doi.org/10.1007/BF00609862
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00609862